managing constipation with semaglutide tirzepatide vs vs. Semaglutide: What's the Difference? When it comes to medical weight management GLP-1 Constipation: Genetics & Management

Who Should Consider COVID IV Therapy & Its Benefits Feeling knocked down by COVID

100% online Price does not increase event if dosage increases as low as $0/month Ozempic Wegovy Mounjaro Zepbound as low as $70/month Semaglutide Tirzepatide as low as $200/month when purchased quarterly Find the weight loss medication right for you Zepbound and Wegovy are FDA-approved for weight loss

Please call our office to learn about our latest promotions

Pfizer CEO Hints at 3 Weight-Loss Drugs During a Semafor event interview on June 24, 2024, Pfizer CEO Alfred Bourla noted that Pfizer is currently working on three weight-loss treatments

Not to get too deep into the science, but a PPAR agonist delivered selectively because of GLP1 and GIP receptors may mean that we can see the insulin sensitizing benefit of this drug class without the negative side effects that prior meds in this class have suffered from